Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 24 , ISSUE 6 ( June, 2020 ) > List of Articles


Antiplatelet Agents in Sepsis—Putting it all together: A Call to Action

Nishant R Tiwari, Kaustubh S Chaudhari, Kevin P Haas, Vivek R Sharma

Citation Information : Tiwari NR, Chaudhari KS, Haas KP, Sharma VR. Antiplatelet Agents in Sepsis—Putting it all together: A Call to Action. Indian J Crit Care Med 2020; 24 (6):483-484.

DOI: 10.5005/jp-journals-10071-23450

License: CC BY-NC 4.0

Published Online: 30-07-2020

Copyright Statement:  Copyright © 2020; The Author(s).


PDF Share
  1. Torio CM, Andrews RM. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011: Statistical Brief #160. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD) 2006.
  2. Wang Y, Ouyang Y, Liu B, Ma X, Ding R. Platelet activation and antiplatelet therapy in sepsis: A narrative review. Thromb Res 2018;166:28–36. DOI: 10.1016/j.thromres.2018.04.007.
  3. Tsao CM, Ho ST, Wu CC. Coagulation abnormalities in sepsis. Acta Anaesthesiol Taiwan 2015;53(1):16–22. DOI: 10.1016/j.aat.2014.11.002.
  4. Salat A, Bodingbauer G, Boehm D, Murabito M, Tochkow E, Sautner T, et al. Changes of platelet surface antigens in patients suffering from abdominal septic shock. Thromb Res 1999;95(6):289–294. DOI: 10.1016/S0049-3848(99)00046-8.
  5. Du F, Jiang P, He S, Song D, Xu F. Antiplatelet therapy for critically ill patients: A Pairwise and Bayesian network meta-analysis. Shock 2018;49(6):616–624. DOI: 10.1097/SHK.0000000000001057.
  6. Ouyang Y, Wang Y, Liu B, Ma X, Ding R. Effects of antiplatelet therapy on the mortality rate of patients with sepsis: A meta-analysis. J Crit Care 2019;50:162–168. DOI: 10.1016/j.jcrc.2018.12.004.
  7. Winning J, Reichel J, Eisenhut Y, Hamacher J, Kohl M, Deigner HP, et al. Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms. Platelets 2009;20(1):50–57. DOI: 10.1080/09537100802503368.
  8. Akinosoglou K, Alexopoulos D. Use of antiplatelet agents in sepsis: a glimpse into the future. Thromb Res 2014;133(2):131–138. DOI: 10.1016/j.thromres.2013.07.002.
  9. Eisen DP, Moore EM, Leder K, Lockery J, McBryde ES, McNeil JJ, et al. Aspirin to inhibit sepsis (antisepsis) randomised controlled trial protocol. BMJ Open 2017;7(1):e013636. DOI: 10.1136/bmjopen-2016-013636.
  10. Kiers D, van der Heijden WA, van Ede L, Gerretsen J, de Mast Q, van der Ven AJ, et al. A randomised trial on the effect of anti-platelet therapy on the systemic inflammatory response in human endotoxaemia. Thromb Haemost 2017;117(9):1798–1807. DOI: 10.1160/TH16- 10-0799.
  11. Thomas MR, Outteridge SN, Ajjan RA, Phoenix F, Sangha GK, Faulkner RE, et al. Platelet P2Y12 inhibitors reduce systemic inflammation and its prothrombotic effects in an experimental human model. Arterioscler Thromb Vasc Biol 2015;35(12):2562–2570. DOI: 10.1161/ATVBAHA.115.306528.
  12. Liverani E, Rico MC, Tsygankov AY, Kilpatrick LE, Kunapuli SP. P2Y12 receptor modulates sepsis-induced inflammation. Arterioscler Thromb Vasc Biol 2016;36(5):961–971. DOI: 10.1161/ATVBAHA.116.307401.
  13. Seidel M, Winning J, Claus RA, Bauer M, Losche W. Beneficial effect of clopidogrel in a mouse model of polymicrobial sepsis. J Thromb Haemost 2009;7(6):1030–1032. DOI: 10.1111/j.1538-7836.2009.03352.x.
  14. Sharron M, Hoptay CE, Wiles AA, Garvin LM, Geha M, Benton AS, et al. Platelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb/IIIa blockade. PLoS ONE 2012;7(7):e41549. DOI: 10.1371/journal.pone.0041549.
  15. Valerio-Rojas JC, Jaffer IJ, Kor DJ, Gajic O, Cartin-Ceba R. Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: a historical cohort study. Crit Care Res Pract 2013;2013:782573. DOI: 10.1155/2013/782573.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.